NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,862 | +8.3% | 2,708 | +7.3% | 0.30% | +13.7% |
| Q2 2023 | $254,621 | +9.7% | 2,523 | 0.0% | 0.26% | +6.1% |
| Q1 2023 | $232,139 | +1.4% | 2,523 | 0.0% | 0.25% | +3.8% |
| Q4 2022 | $228,909 | +6.0% | 2,523 | -1.2% | 0.24% | +10.7% |
| Q2 2022 | $216,000 | -11.8% | 2,553 | -8.6% | 0.22% | -0.5% |
| Q1 2022 | $245,000 | +0.4% | 2,793 | 0.0% | 0.22% | +10.2% |
| Q4 2021 | $244,000 | +7.0% | 2,793 | 0.0% | 0.20% | +6.5% |
| Q3 2021 | $228,000 | -10.6% | 2,793 | 0.0% | 0.18% | -10.7% |
| Q2 2021 | $255,000 | +6.7% | 2,793 | 0.0% | 0.21% | -1.0% |
| Q1 2021 | $239,000 | -9.5% | 2,793 | -0.1% | 0.21% | -15.8% |
| Q4 2020 | $264,000 | +2833.3% | 2,797 | +2697.0% | 0.25% | +1664.3% |
| Q3 2015 | $9,000 | -10.0% | 100 | 0.0% | 0.01% | +75.0% |
| Q2 2015 | $10,000 | 0.0% | 100 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $10,000 | +11.1% | 100 | 0.0% | 0.01% | +14.3% |
| Q4 2014 | $9,000 | – | 100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |